Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,527,883
+$57,332 QoQ
Shares Held
6,016
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#2,584
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Westover Capital Advisors, LLC holds $13,813,106 across 9 Drug Manufacturers - General names. JNJ ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,728 | $4,471,475 | |
| 2 | ABBV |
AbbVie Inc.
|
8,549 | $2,151,270 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
15,885 | $2,006,910 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
6,016 | $1,527,883 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,716 | $1,505,506 | |
| 6 | AMGN |
Amgen Inc
|
2,375 | $860,035 | |
| 7 | AZN |
Astrazeneca PLC
|
4,458 | $845,325 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,182 | $240,966 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,527,883 | 6,016 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,470,551 | 6,016 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,245,011 | 6,016 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,115,486 | 6,016 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $918,944 | 6,016 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,022,735 | 6,167 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $865,261 | 5,983 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $980,625 | 6,051 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $874,475 | 5,983 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $497,665 | 3,146 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $521,630 | 3,328 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $489,989 | 3,146 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $548,864 | 3,316 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $549,010 | 3,542 | Shares | Sole | 2023-05-22 | |
| 2022-12-31 | $625,694 | 3,542 | Shares | Sole | 2023-05-18 | |
| 2022-09-30 | $543,008 | 3,324 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $597,143 | 3,364 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $596,201 | 3,364 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $529,290 | 3,094 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $583,822 | 3,615 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $588,945 | 3,575 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $526,741 | 3,205 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $516,835 | 3,284 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $456,614 | 3,067 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $394,748 | 2,807 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $455,283 | 3,472 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||